![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Doximity Inc | NYSE:DOCS | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-1.40 | -4.83% | 27.5901 | 27.945 | 26.50 | 26.61 | 2,362,638 | 01:00:00 |
Fiscal year 2024 total revenues of $475.4 million, up 13% year-over-year Fiscal year 2024 net income growth of 31% and adjusted EBITDA growth of 25% year-over-year
Q4 total revenues of $118.1 million, up 6% year-over-year Q4 net income growth of 32% and adjusted EBITDA growth of 15% year-over-year
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 fourth quarter and fiscal year ended March 31, 2024.
“We were pleased to beat on our top and bottom lines, as we delivered another quarter of strong profits and record engagement,” said Jeff Tangney, co-founder and CEO of Doximity. “We’re proud to bring AI and automation to clinical workflows, with over 580,000 unique providers using our workflow tools last quarter.”
Fiscal 2024 Fourth Quarter Financial Highlights
All comparisons, unless otherwise noted, are to the three months ended March 31, 2023.
Fiscal Year 2024 Financial Highlights
All comparisons, unless otherwise noted, are to the fiscal year ended March 31, 2023.
Financial Outlook
Doximity is providing guidance for its fiscal first quarter ending June 30, 2024 as follows:
Doximity is providing guidance for its fiscal year ending March 31, 2025 as follows:
Stock Repurchase Program
On May 1, 2024 the Company’s board of directors authorized a program to repurchase up to $500 million of the Company’s Class A common stock. The repurchase program has no expiration date and is subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock. All prior repurchase programs were completed as of April 2024.
Conference Call Information
Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.
About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.
Forward-Looking Statements
Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in the Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2023. Additional information will be provided in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
DOXIMITY, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
March 31, 2024
March 31, 2023
Assets
Current assets:
Cash and cash equivalents
$
96,785
$
158,027
Marketable securities
666,115
682,972
Accounts receivable, net
101,332
107,047
Prepaid expenses and other current assets
48,709
27,407
Total current assets
912,941
975,453
Property and equipment, net
12,318
11,279
Deferred income tax assets
45,068
34,907
Operating lease right-of-use assets
12,332
13,819
Intangible assets, net
27,317
31,836
Goodwill
67,940
67,940
Other assets
1,458
1,654
Total assets
$
1,079,374
$
1,136,888
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
$
2,253
$
1,272
Accrued expenses and other current liabilities
43,703
31,245
Deferred revenue, current
99,145
105,238
Operating lease liabilities, current
2,149
1,752
Total current liabilities
147,250
139,507
Deferred revenue, non-current
211
198
Operating lease liabilities, non-current
12,397
13,885
Contingent earn-out consideration liability, non-current
10,895
15,942
Other liabilities, non-current
7,224
1,240
Total liabilities
177,977
170,772
Stockholders' Equity
Preferred stock
—
—
Common stock
187
194
Additional paid-in capital
823,885
762,150
Accumulated other comprehensive loss
(2,664
)
(14,083
)
Retained earnings
79,989
217,855
Total stockholders' equity
901,397
966,116
Total liabilities and stockholders’ equity
$
1,079,374
$
1,136,888
DOXIMITY, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended March 31,
Fiscal Year Ended March 31,
2024
2023
2024
2023
Revenue
$
118,057
$
110,966
$
475,422
$
419,052
Cost of revenue(1)
12,567
13,677
50,669
53,490
Gross profit
105,490
97,289
424,753
365,562
Operating expenses(1):
Research and development
20,148
21,541
81,983
80,186
Sales and marketing
33,517
33,148
133,129
123,523
General and administrative
9,973
9,759
37,827
36,745
Restructuring
—
—
7,936
—
Total operating expenses
63,638
64,448
260,875
240,454
Income from operations
41,852
32,841
163,878
125,108
Other income, net
6,101
3,875
21,324
8,048
Income before income taxes
47,953
36,716
185,202
133,156
Provision for income taxes
7,335
6,048
37,620
20,338
Net income
$
40,618
$
30,668
$
147,582
$
112,818
Net income per share attributable to Class A and Class B common stockholders:
Basic
$
0.22
$
0.16
$
0.78
$
0.58
Diluted
$
0.20
$
0.14
$
0.72
$
0.53
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic
186,756
193,829
190,172
193,176
Diluted
201,110
212,742
205,734
213,425
(1) Costs and expenses include stock-based compensation expense as follows (in thousands):
Three Months Ended March 31,
Fiscal Year Ended March 31,
2024
2023
2024
2023
Cost of revenue
$
2,274
$
2,425
$
9,479
$
9,634
Research and development
3,104
3,167
11,978
12,583
Sales and marketing
4,105
5,027
16,857
16,939
General and administrative
2,374
2,372
9,116
8,678
Restructuring
—
—
3,646
—
Total stock-based compensation expense
$
11,857
$
12,991
$
51,076
$
47,834
DOXIMITY, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Three Months Ended March 31,
Fiscal Year Ended March 31,
2024
2023
2024
2023
Cash flows from operating activities
Net income
$
40,618
$
30,668
$
147,582
$
112,818
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
2,548
2,708
10,265
10,283
Deferred income taxes
(8,593
)
3,834
(8,593
)
13,226
Stock-based compensation, net of amounts capitalized
11,857
12,991
51,076
47,834
Non-cash lease expense
475
537
2,074
2,027
Amortization of premium (accretion of discount) on marketable securities, net
(1,761
)
(29
)
(5,238
)
3,115
Net loss on sale of marketable securities
—
—
402
1,093
Amortization of deferred contract costs
2,593
2,428
8,871
8,785
Change in fair value of contingent earn-out consideration liability
183
405
951
728
Other
773
252
1,230
726
Changes in operating assets and liabilities, net of effect of acquisition:
Accounts receivable
(4,516
)
(32,433
)
3,993
(26,242
)
Prepaid expenses and other assets
(16,502
)
(5,372
)
(20,483
)
(3,448
)
Deferred contract costs
(1,683
)
(2,053
)
(8,608
)
(8,462
)
Accounts payable, accrued expenses and other liabilities
5,966
(2,918
)
8,332
(195
)
Deferred revenue
32,496
35,625
(6,080
)
17,527
Operating lease liabilities
(510
)
(4
)
(1,678
)
(213
)
Net cash provided by operating activities
63,944
46,639
184,096
179,602
Cash flows from investing activities
Cash paid for acquisition
—
—
—
(53,500
)
Purchases of property and equipment
—
(21
)
(147
)
(1,701
)
Internal-use software development costs
(1,634
)
(1,005
)
(5,654
)
(4,483
)
Purchases of marketable securities
(191,529
)
(60,303
)
(472,867
)
(190,560
)
Maturities of marketable securities
116,993
48,125
435,179
83,139
Sales of marketable securities
—
—
74,675
107,182
Net cash provided by (used in) investing activities
(76,170
)
(13,204
)
31,186
(59,923
)
Cash flows from financing activities
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants
3,134
2,471
12,892
9,926
Proceeds from issuance of common stock in connection with the employee stock purchase plan
1,952
2,418
3,446
4,759
Taxes paid related to net share settlement of equity awards
(1,424
)
(1,469
)
(6,756
)
(3,822
)
Repurchase of common stock
(17,740
)
(15,282
)
(280,716
)
(85,324
)
Payment of contingent consideration related to a business combination
—
—
(5,390
)
—
Net cash used in financing activities
(14,078
)
(11,862
)
(276,524
)
(74,461
)
Net increase (decrease) in cash and cash equivalents
(26,304
)
21,573
(61,242
)
45,218
Cash and cash equivalents, beginning of period
123,089
136,454
158,027
112,809
Cash and cash equivalents, end of period
$
96,785
$
158,027
$
96,785
$
158,027
Supplemental disclosures of cash flow information
Cash paid for taxes, net of refunds
$
12,911
$
2,727
$
51,274
$
5,231
Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:
We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.
Key Business Metrics
Reconciliation of GAAP to Non-GAAP Financial Measures
The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:
Three Months Ended March 31,
Fiscal Year Ended March 31,
2024
2023
2024
2023
(unaudited)
(in thousands, except percentages)
Net income
$
40,618
$
30,668
$
147,582
$
112,818
Adjusted to exclude the following:
Acquisition and other related expenses
—
—
—
30
Stock-based compensation
11,857
12,991
47,430
47,834
Depreciation and amortization
2,548
2,708
10,265
10,283
Provision for income taxes
7,335
6,048
37,620
20,338
Restructuring expense
—
—
7,936
—
Change in fair value of contingent earn-out consideration liability
183
405
951
728
Other income, net
(6,101
)
(3,875
)
(21,324
)
(8,048
)
Adjusted EBITDA
$
56,440
$
48,945
$
230,460
$
183,983
Revenue
$
118,057
$
110,966
$
475,422
$
419,052
Net income margin
34.4
%
27.6
%
31.0
%
26.9
%
Adjusted EBITDA margin
47.8
%
44.1
%
48.5
%
43.9
%
Three Months Ended March 31,
Fiscal Year Ended March 31,
2024
2023
2024
2023
(unaudited)
(in thousands)
Net cash provided by operating activities
$
63,944
$
46,639
$
184,096
$
179,602
Purchases of property and equipment
—
(21
)
(147
)
(1,701
)
Internal-use software development costs
(1,634
)
(1,005
)
(5,654
)
(4,483
)
Free cash flow
$
62,310
$
45,613
$
178,295
$
173,418
Other cash flow components:
Net cash provided by (used in) investing activities
$
(76,170
)
$
(13,204
)
$
31,186
$
(59,923
)
Net cash used in financing activities
$
(14,078
)
$
(11,862
)
$
(276,524
)
$
(74,461
)
Three Months Ended March 31,
Fiscal Year Ended March 31,
2024
2023
2024
2023
(unaudited)
(in thousands, except per share data and percentages)
GAAP cost of revenue
$
12,567
$
13,677
$
50,669
$
53,490
Adjusted to exclude the following:
Stock-based compensation
(2,274
)
(2,425
)
(9,479
)
(9,634
)
Amortization of acquired intangibles
—
(137
)
(274
)
(548
)
Non-GAAP cost of revenue
$
10,293
$
11,115
$
40,916
$
43,308
GAAP gross profit
$
105,490
$
97,289
$
424,753
$
365,562
Adjusted to exclude the following:
Stock-based compensation
2,274
2,425
9,479
9,634
Amortization of acquired intangibles
—
137
274
548
Non-GAAP gross profit
$
107,764
$
99,851
$
434,506
$
375,744
GAAP gross margin
89.4
%
87.7
%
89.3
%
87.2
%
Non-GAAP gross margin
91.3
%
90.0
%
91.4
%
89.7
%
GAAP research and development expense
$
20,148
$
21,541
$
81,983
$
80,186
Adjusted to exclude the following:
Stock-based compensation
(3,104
)
(3,167
)
(11,978
)
(12,583
)
Non-GAAP research and development expense
$
17,044
$
18,374
$
70,005
$
67,603
GAAP sales and marketing expense
$
33,517
$
33,148
$
133,129
$
123,523
Adjusted to exclude the following:
Stock-based compensation
(4,105
)
(5,027
)
(16,857
)
(16,939
)
Amortization of acquired intangibles
(1,061
)
(979
)
(4,244
)
(4,164
)
Change in fair value of contingent earn-out consideration liability
(183
)
(405
)
(951
)
(728
)
Non-GAAP sales and marketing expense
$
28,168
$
26,737
$
111,077
$
101,692
GAAP general and administrative expense
$
9,973
$
9,759
$
37,827
$
36,745
Adjusted to exclude the following:
Acquisition and other related expenses
—
—
—
(30
)
Stock-based compensation
(2,374
)
(2,372
)
(9,116
)
(8,678
)
Non-GAAP general and administrative expense
$
7,599
$
7,387
$
28,711
$
28,037
GAAP operating expense
$
63,638
$
64,448
$
260,875
$
240,454
Adjusted to exclude the following:
Acquisition and other related expenses
—
—
—
(30
)
Stock-based compensation
(9,583
)
(10,566
)
(37,951
)
(38,200
)
Amortization of acquired intangibles
(1,061
)
(979
)
(4,244
)
(4,164
)
Change in fair value of contingent earn-out consideration liability
(183
)
(405
)
(951
)
(728
)
Restructuring
—
—
(7,936
)
—
Non-GAAP operating expense
$
52,811
$
52,498
$
209,793
$
197,332
GAAP operating income
$
41,852
$
32,841
$
163,878
$
125,108
Adjusted to exclude the following:
Acquisition and other related expenses
—
—
—
30
Stock-based compensation
11,857
12,991
47,430
47,834
Amortization of acquired intangibles
1,061
1,116
4,518
4,712
Change in fair value of contingent earn-out consideration liability
183
405
951
728
Restructuring
—
—
7,936
—
Non-GAAP operating income
$
54,953
$
47,353
$
224,713
$
178,412
GAAP net income
$
40,618
$
30,668
$
147,582
$
112,818
Adjusted to exclude the following:
Acquisition and other related expenses
—
—
—
30
Stock-based compensation
11,857
12,991
47,430
47,834
Amortization of acquired intangibles
1,061
1,116
4,518
4,712
Change in fair value of contingent earn-out consideration liability
183
405
951
728
Restructuring
—
—
7,936
—
Income tax effect of non-GAAP adjustments (1)
(2,751
)
(3,048
)
(12,775
)
(11,194
)
Non-GAAP net income
$
50,968
$
42,132
$
195,642
$
154,928
Non-GAAP net income margin
43.2
%
38.0
%
41.2
%
37.0
%
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic
186,756
193,829
190,172
193,176
Diluted
201,110
212,742
205,734
213,425
Non-GAAP net income per share attributable to Class A and Class B stockholders:
Basic
$
0.27
$
0.22
$
1.03
$
0.80
Diluted
$
0.25
$
0.20
$
0.95
$
0.73
(1)
For the three months and fiscal years ended March 31, 2024 and 2023, management used an estimated annual effective non-GAAP tax rate of 21.0%.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240516910294/en/
Investor Relations Contact: Perry Gold ir@doximity.com
Media Contact: Amanda Cox pr@doximity.com
1 Year Doximity Chart |
1 Month Doximity Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions